Limelight Bio is Biotechnology in United States that focus on gene editing approaches business. Founded in 2016. They cover business area such as operator, novel gene therapy, proprietary technology, advanced target, lead drug candidate, key limitation, current gene therapy, gene editing approach, severe retinal, hematologic/metabolic, loss disease, patient, treatment.
2016
( 8 years old in 2024 )
Gene Editing Approaches
-
3401 Grays Ferry Avenue
Philadelphia, PA 19146
United States
Private
operatornovel gene therapyproprietary technologyadvanced targetlead drug candidatekey limitationcurrent gene therapygene editing approachsevere retinal, hematologic/metabolicloss diseasepatienttreatment
* We use standard office opening hours in near Limelight Bio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Limelight Bio is Biotechnology business from United States that founded in 2016 (8 years old in 2024), Limelight Bio business is focusing on Gene Editing Approaches.
Limelight Bio headquarter office and corporate office address is located in 3401 Grays Ferry Avenue Philadelphia, PA 19146 United States.
Limelight Bio was founded in United States.
In 2024, Limelight Bio is currently focus on gene editing approaches sector.
Above is snippet of Google Trends for "gene editing approaches" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Limelight Bio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
